マイクロRNA市場：アッセイタイプ、製品タイプ、サービスタイプ、用途別-2025～2030年の世界予測

マイクロRNA市場は、2023年に21億2,000万米ドルと評価され、2024年には27億2,000万米ドルに達すると予想され、CAGR 28.84％で成長し、2030年には125億1,000万米ドルに達すると予測されています。

マイクロRNA（miRNA）は、遺伝子発現の調節に重要な役割を果たす小さなノンコーディングRNA分子であり、発生、分化、アポトーシス、代謝などの様々な生物学的プロセスにおいて重要な役割を果たしています。miRNA研究の必要性は、主に腫瘍学、心血管疾患、神経変性疾患などの疾患診断、治療、個別化医療への応用の可能性に由来します。miRNAの最終用途には、製薬会社、学術研究機関、診断センターが含まれます。miRNA市場に影響を与える主要成長要因としては、次世代シーケンス技術の進歩、慢性疾患の有病率の増加、ゲノミクス研究への資金提供の増加などが挙げられます。最新のビジネス機会は、バイオマーカー探索を強化するための人工知能とmiRNAの統合や、特に遺伝性疾患やがんを対象としたmiRNAベースの治療の開発にあります。このような機会を活用するために、企業はナノ技術のような革新的な送達システムの研究開発に投資し、学術機関と協力して探索段階を加速させるべきです。

しかし、市場はmiRNAの生合成の複雑さ、治療へのデリバリーの課題、厳しい規制の枠組みなどの限界に直面しています。サンプルの取り扱いやデータのばらつきといった技術的な問題も大きな課題となっています。包括的なmiRNAプロファイリングのための強固な多重化技術を開発し、データ分析のための計算ツールを改良して予測モデリングの精度を高めることで、イノベーションを推進することができます。利害関係者間の共同研究は、研究成果をさらに増幅し、新開発の市場投入までの時間を短縮することができます。miRNAのセグメントはダイナミックで日進月歩であり、機敏な戦略と規制の変化や技術の進歩への適応性が求められます。規制状況を継続的にモニタリングし、官民のパートナーシップを促進することは、成長の課題を克服する助けとなります。企業は競合を維持するために、個別化医療ソリューションの構築と非侵襲的診断のためのアッセイ開発の拡大に注力すべきです。臨床上のギャップを埋めるためのトランスレーショナルリサーチの展開も、長期的な市場ポテンシャルと患者中心の成果を達成するための極めて主要ポイントとなります。

市場力学：急速に進化するマイクロRNA市場の主要市場洞察を公開

マイクロRNA市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の罹患率の上昇とがん患者の増加
  • 複数の疾患の診断におけるマイクロRNAの重要性の高まり
  • マイクロRNAの可能性を探る世界の調査活動の増加
• 市場抑制要因
  • マイクロRNAキットやその他の製品に関連する高コスト
• 市場機会
  • 疾患関連分析用途のためのマイクロRNAツールの出現
  • ゲノム研究の進展と研究活動を支援する新しいツールの採用
• 市場課題
  • マイクロRNAの安全性と毒性の問題

ポーターのファイブフォース：マイクロRNA市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、マイクロRNA市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：マイクロRNA市場における外部からの影響の把握

外部マクロ環境要因は、マイクロRNA市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：マイクロRNA市場における競合情勢の把握

マイクロRNA市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：マイクロRNA市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、マイクロRNA市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：マイクロRNA市場における成功への道筋を描く

マイクロRNA市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の発症率とがんの症例数の増加
    • さまざまな病気の診断におけるマイクロRNAの重要性の高まり
    • マイクロRNAの可能性を世界規模で探る調査活動の拡大
  • 抑制要因
    • マイクロRNAキットやその他の製品に関連する高コスト
  • 機会
    • 疾患関連分析用途のための新たなマイクロRNAツール
    • ゲノム研究の進歩と調査活動を支援するための新しいツールの導入
  • 課題
    • マイクロRNAの安全性と毒性の問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 マイクロRNA市場：アッセイタイプ別

• イントロダクション
• 化学発光アッセイ
• 比色アッセイ
• 蛍光アッセイ
• 免疫測定
• miRNAアレイ
• 次世代シーケンシング
• PCRベースのアッセイ

第7章 マイクロRNA市場：製品別

• イントロダクション
• 消耗品
• 機器

第8章 マイクロRNA市場：サービスタイプ別

• イントロダクション
• 機能研究サービス
• マイクロアレイサービス

第9章 マイクロRNA市場：用途別

• イントロダクション
• がん
• 心血管疾患
• 免疫疾患
• 感染症
• 神経疾患

第10章 南北アメリカのマイクロRNA市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のマイクロRNA市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのマイクロRNA市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abcam PLC
• Bio-Rad Laboratories, Inc.
• Global Life Sciences Solutions USA LLC
• HTG Molecular Diagnostics, Inc.
• Illumina, Inc.
• Integrated DNA Technologies, Inc
• Lexogen GmbH
• Meridian Bioscience Inc
• New England Biolabs (UK) Ltd.
• Norgen BIoTek Corp.
• Oxford Nanopore Technologies Limited
• Rosetta Genomics Ltd.
• Sigma Aldrich Corp.
• System Biosciences, LLC
• Thermo Fisher Scientific Inc.
• TriLink BioTechnologies, Inc.

LIST OF FIGURES

• FIGURE 1. MICRORNA MARKET RESEARCH PROCESS
• FIGURE 2. MICRORNA MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MICRORNA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MICRORNA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. MICRORNA MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. MICRORNA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MICRORNA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MICRORNA MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MICRORNA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MICRORNA MARKET DYNAMICS
• TABLE 7. GLOBAL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MICRORNA MARKET SIZE, BY CHEMILUMINESCENT ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MICRORNA MARKET SIZE, BY COLORIMETRIC ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MICRORNA MARKET SIZE, BY FLUORESCENT ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MICRORNA MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MICRORNA MARKET SIZE, BY MIRNA ARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MICRORNA MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MICRORNA MARKET SIZE, BY PCR-BASED ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MICRORNA MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MICRORNA MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MICRORNA MARKET SIZE, BY FUNCTIONAL STUDIES SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MICRORNA MARKET SIZE, BY MICROARRAY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MICRORNA MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MICRORNA MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MICRORNA MARKET SIZE, BY IMMUNOLOGICAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MICRORNA MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL MICRORNA MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. CANADA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. CANADA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES MICRORNA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. CHINA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. CHINA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. CHINA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 65. CHINA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. INDIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. INDIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA MICRORNA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. ITALY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ITALY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. ITALY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 138. ITALY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. POLAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. POLAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. POLAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 154. POLAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. QATAR MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. QATAR MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. QATAR MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 158. QATAR MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM MICRORNA MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM MICRORNA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM MICRORNA MARKET SIZE, BY SERVICES TYPE, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM MICRORNA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. MICRORNA MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 196. MICRORNA MARKET, FPNV POSITIONING MATRIX, 2023

The microRNA Market was valued at USD 2.12 billion in 2023, expected to reach USD 2.72 billion in 2024, and is projected to grow at a CAGR of 28.84%, to USD 12.51 billion by 2030.

MicroRNAs (miRNAs) are small non-coding RNA molecules playing a crucial role in regulating gene expression, making them significant in various biological processes such as development, differentiation, apoptosis, and metabolism. The necessity of miRNA research stems from its potential applications in disease diagnostics, therapeutics, and personalized medicine, predominantly in oncology, cardiovascular diseases, and neurodegenerative disorders. The end-use of miRNAs encompasses pharmaceutical companies, academic and research institutions, and diagnostic centers. Key growth factors influencing the miRNA market include advancements in next-generation sequencing technologies, growing prevalence of chronic diseases, and increased funding in genomics research. The latest opportunities lie in the integration of miRNA with artificial intelligence for enhanced biomarker discovery and in developing miRNA-based therapeutics, specifically targeting genetic disorders and cancers. To leverage these opportunities, companies should invest in R&D for innovative delivery systems like nanotechnology and collaborate with academic institutions to accelerate discovery phases.

However, the market faces limitations such as the complexity of miRNA biogenesis, delivery challenges in therapeutics, and stringent regulatory frameworks. Technical issues in sample handling and data variability also pose significant challenges. Forging ahead, innovation can be driven by developing robust multiplexing technologies for comprehensive miRNA profiling and improving computational tools for data analysis to enhance predictive modeling accuracy. Collaborations among stakeholders can further amplify research outputs and reduce time-to-market for new developments. The miRNA sector is dynamic and fast-evolving, demanding agile strategies and adaptability to regulatory changes and technological advances. Continuous monitoring of regulatory landscapes and fostering public-private partnerships can aid in overcoming growth challenges. Businesses should focus on building personalized medicine solutions and expanding the assay development for non-invasive diagnostics to stay competitive. Deploying translational research to bridge clinical gaps can also serve as a pivotal point for achieving long-term market potential and patient-centric outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving microRNA Market

The microRNA Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of chronic diseases and rising number of cancer cases
  • Growing importance of microRNA for the diagnosis of several diseases
  • Increasing research activities exploring the potential of microRNA globally
• Market Restraints
  • High cost associated with microRNA kits and other products
• Market Opportunities
  • Emerging microRNA tools for disease-associated analytical applications
  • Advancement in genomic studies and adoption of new tools for supporting research endeavors
• Market Challenges
  • Safety and toxicity issues of microRNA

Porter's Five Forces: A Strategic Tool for Navigating the microRNA Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the microRNA Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the microRNA Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the microRNA Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the microRNA Market

A detailed market share analysis in the microRNA Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the microRNA Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the microRNA Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the microRNA Market

A strategic analysis of the microRNA Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the microRNA Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Bio-Rad Laboratories, Inc., Global Life Sciences Solutions USA LLC, HTG Molecular Diagnostics, Inc., Illumina, Inc., Integrated DNA Technologies, Inc, Lexogen GmbH, Meridian Bioscience Inc, New England Biolabs (UK) Ltd., Norgen Biotek Corp., Oxford Nanopore Technologies Limited, Rosetta Genomics Ltd., Sigma Aldrich Corp., System Biosciences, LLC, Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..

Market Segmentation & Coverage

This research report categorizes the microRNA Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Assay Type, market is studied across Chemiluminescent Assays, Colorimetric Assays, Fluorescent Assays, Immunoassay, miRNA Arrays, Next-Generation Sequencing, and PCR-Based Assay.
• Based on Product, market is studied across Consumables and Instruments.
• Based on Services Type, market is studied across Functional Studies Services and Microarray Services.
• Based on Application, market is studied across Cancer, Cardiovascular Disease, Immunological Disorder, Infectious Diseases, and Neurological Diseases.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of chronic diseases and rising number of cancer cases
    • 5.1.1.2. Growing importance of microRNA for the diagnosis of several diseases
    • 5.1.1.3. Increasing research activities exploring the potential of microRNA globally
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with microRNA kits and other products
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging microRNA tools for disease-associated analytical applications
    • 5.1.3.2. Advancement in genomic studies and adoption of new tools for supporting research endeavors
  • 5.1.4. Challenges
    • 5.1.4.1. Safety and toxicity issues of microRNA
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. microRNA Market, by Assay Type

• 6.1. Introduction
• 6.2. Chemiluminescent Assays
• 6.3. Colorimetric Assays
• 6.4. Fluorescent Assays
• 6.5. Immunoassay
• 6.6. miRNA Arrays
• 6.7. Next-Generation Sequencing
• 6.8. PCR-Based Assay

7. microRNA Market, by Product

• 7.1. Introduction
• 7.2. Consumables
• 7.3. Instruments

8. microRNA Market, by Services Type

• 8.1. Introduction
• 8.2. Functional Studies Services
• 8.3. Microarray Services

9. microRNA Market, by Application

• 9.1. Introduction
• 9.2. Cancer
• 9.3. Cardiovascular Disease
• 9.4. Immunological Disorder
• 9.5. Infectious Diseases
• 9.6. Neurological Diseases

10. Americas microRNA Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific microRNA Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa microRNA Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam PLC
• 2. Bio-Rad Laboratories, Inc.
• 3. Global Life Sciences Solutions USA LLC
• 4. HTG Molecular Diagnostics, Inc.
• 5. Illumina, Inc.
• 6. Integrated DNA Technologies, Inc
• 7. Lexogen GmbH
• 8. Meridian Bioscience Inc
• 9. New England Biolabs (UK) Ltd.
• 10. Norgen Biotek Corp.
• 11. Oxford Nanopore Technologies Limited
• 12. Rosetta Genomics Ltd.
• 13. Sigma Aldrich Corp.
• 14. System Biosciences, LLC
• 15. Thermo Fisher Scientific Inc.
• 16. TriLink BioTechnologies, Inc.